Your browser doesn't support javascript.
loading
New discovery of high-affinity SARS-CoV-2 spike S2 protein binding peptide selected by PhIP-Seq.
Chen, Mengyuan; He, Shuizhen; Xiong, Hualong; Zhang, Dongxu; Wang, Shaojuan; Hou, Wangheng; Zhu, Xiaomei; Wang, Jin; Huang, Yang; Hong, Congming; Wu, Yubin; Qi, Ruoyao; Zhang, Tianying; Yuan, Quan; Li, Tingdong; Chen, Yixin; Zhang, Shiyin; Ge, Shengxiang; Zhang, Jun; Xia, Ningshao.
Afiliação
  • Chen M; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
  • He S; Xiamen Haicang Hospital, Haiyu Road, Xiamen, 361026, China.
  • Xiong H; School of Life Sciences, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
  • Zhang D; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
  • Wang S; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
  • Hou W; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
  • Zhu X; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
  • Wang J; School of Life Sciences, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
  • Huang Y; School of Life Sciences, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
  • Hong C; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
  • Wu Y; School of Life Sciences, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
  • Qi R; School of Life Sciences, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
  • Zhang T; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
  • Yuan Q; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
  • Li T; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
  • Chen Y; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
  • Zhang S; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, South Xiang'an Road, Xiamen, 361102, China. Electronic address: zhangshiyin@xmu.edu.cn.
  • Ge S; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, South Xiang'an Road, Xiamen, 361102, China. Electronic address: sxge@xmu.edu.cn.
  • Zhang J; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
  • Xia N; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, South Xiang'an Road, Xiamen, 361102, China.
Virol Sin ; 37(5): 758-761, 2022 10.
Article em En | MEDLINE | ID: mdl-35803529

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article